New Deals for New Therapies: How Hospitals Can Help
Cell and gene medicines promise lasting cures, but they cost a lot upfront and their long‑term safety is still being studied. Because of this, drug makers and insurers are turning to value‑based contracts that link payment to how well the treatments actually work in real life. These agreements are g